Thyroglossal duct cysts (TGDCs) are present in ~7% of adults and develop from the midline migratory tract between the foramen cecum and anatomic location of the thyroid. Thyroid tissue can be identified in 2/3 of TGDCs, and up to 1% develop associated malignancy, 90% of which are papillary thyroid carcinoma. Cases of follicular and anaplastic carcinoma have been documented, but there are no reports of medullary thyroid carcinoma arising in a TGDC. This is presumably due to the distinct embryologic origin of parafollicular C-cells, from which medullary carcinoma arises. The goal of this study is to determine whether parafollicular C-cells are present in TGDCs. H&E sections from 41 TGDC cases were examined for thyroid tissue, thyroglossal duct remnants, ultimobranchial remnants, and parafollicular C-cells. Immunohistochemistry was performed for TTF-1 and calcitonin. Eighty three percent (34/41) of cases contained thyroid tissue on H&E and by TTF-1. No cases (0/41) had ultimobranchial remnants or parafollicular C-cells on H&E or with calcitonin. One case of papillary carcinoma in a TGDC was identified. These cases illustrate that although TGDCs often contain thyroid tissue, parafollicular C-cells are absent. Therefore, unlike other thyroid neoplasms, there is no evidence to support the possibility of medullary carcinoma arising in a TGDC.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873481PMC
http://dx.doi.org/10.1007/s12105-017-0826-xDOI Listing

Publication Analysis

Top Keywords

parafollicular c-cells
24
thyroid tissue
16
thyroid carcinoma
12
thyroglossal duct
12
medullary thyroid
8
thyroid
8
carcinoma arising
8
arising tgdc
8
medullary carcinoma
8
ultimobranchial remnants
8

Similar Publications

Medullary thyroid carcinoma (MTC), a rare neuroendocrine tumor comprising 3-5% of thyroid cancers, arises from calcitonin-producing parafollicular C cells. Despite aggressive behavior, surgery remains the primary curative treatment, with limited efficacy reported for radiotherapy and chemotherapy. Recent efforts have explored the pathogenetic mechanisms of MTC, identifying it as a highly vascularized neoplasm overexpressing pro-angiogenic factors.

View Article and Find Full Text PDF
Article Synopsis
  • - Medullary Thyroid Carcinoma (MTC) is a rare but aggressive thyroid cancer that develops from C-cells, which produce calcitonin, and is known for its high potential to spread.
  • - The genetics of MTC, especially involving the RET gene and the RAS gene family, have been crucial in understanding the disease and finding possible treatment targets.
  • - This review highlights recent progress in MTC genetics, new precision therapies, and potential biomarkers, discussing their significance for clinical practice and future research directions.
View Article and Find Full Text PDF

Medullary Thyroid Carcinoma: A Unique Case Report.

Cureus

July 2024

Department of Pathology, Saveetha Medical College and Hospitals, Saveetha Institute of Medical Sciences, Saveetha University, Chennai, IND.

Article Synopsis
  • - Medullary thyroid carcinoma is a rare tumor originating from parafollicular C-cells, linked to hereditary syndromes like FMTC and MEN 2, or it can occur randomly.
  • - A case is reported involving a 50-year-old man diagnosed with the cancer after a neck mass was identified and examined through fine needle aspiration and histopathology.
  • - Key markers for diagnosis and monitoring include carcinoembryonic antigen (CEA) and calcitonin, highlighting the importance of early detection and treatment for better survival rates.
View Article and Find Full Text PDF

Effect of PGE2 on TT cells viability and division.

Prostaglandins Other Lipid Mediat

October 2024

Department of Optometry, MacKay Junior College of Medicine, Nursing, and Management, No.92, Shengjing Rd., Beitou District, Taipei 112021, Taiwan, ROC. Electronic address:

Previous studies have shown prostaglandin E2 (PGE2) produced a marked increase in calcitonin secretion in human C-cells derived from medullary thyroid carcinoma. However, it's unclear whether PGE2 can increase the growth of C cells. In this study, we use TT cells as a C cell model to investigate the effect of PGE2 on the growth of C cells.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!